Your health is personal. 

So why isn't your treatment?

Physicians currently determine your medicine dose based upon your body weight or size. This approach poorly considers the large variability in how individual patients distribute, break-down and clear drugs from the body.

Four people of different ages and ethnicities

There are many complicating factors which contribute to these differences, including gender, age, ethnicity, nutrition and well-being. None of these are accounted for using traditional dosing approaches.

This leads to irregularity and fluctuations between patients in terms of how much drug is in the blood and how long the drug stays there - also known as medicine exposure. 


Such practices have led to many patients suffering from poorly treated conditions or dealing with life-limiting side effects associated with critical medicine.

  Who we help

Patients groups especially disadvantaged with the ‘one size fits all’ dosing approach include:​​ 

Brown-haired girl in a green t-shirt

Paediatrics (under 16 years of age)

Black-haired man in a pink shirt

Patients on dose intense regimens

An elderly man in a dark blue shirt


Little boy in a purple t-shirt

Patients with rare genetic disorders

Woman in a turquoise blouse

Small and large physiques

Red-haired young woman in a green blouse

Patients on narrow therapeutic index drugs

Vesynta elevates medicine safety and effectiveness for these groups and others.

Our team is revolutionising bedside patient monitoring to generate medicine exposure data,
that enables individualised treatment for better health outcomes.

Our approach

Physicians require a reliable method to aid routine treatment modifications according to individual patient response.


A lack of real-time patient data makes this practice a clinical challenge. 

Vesynta's platform is developed in partnership with world leaders in drug monitoring and clinical pharmacology.

Vesynta's technology combines automated desktop hardware with analytical software to provide a universal bedside platform for medicine exposure analysis from patient blood. 

This information provides the clinician with an understanding of the patient's pharmacology to support smarter clinical decisions that are tailored to the individual.

Our data-guided dosing approach ensures the best possible treatment against all clinical endpoints, across all patients and medicines. 

The value of bedside
personalised care

Earlier medicines optimisation Personalised dose modifications to safer and more effective levels 

Improving patient life quality
Reducing adverse events and sub-optimal treatment

Ensure data quality and security

Reliable response prediction and continuous refinement 

A doctor shaking a patient's hand with his mother. A point of care drug monitoring device in the background.

Champion care standards
Focus on under-represented patients such as children

Empower patients and physicians

Full treatment ownership is provided via point-of-care access, ease of use and automation

Interested in Vesynta?